FDA Reviewing Request to Approve ADS-5102 to Treat Levodopa-induced Dyskinesia
The U.S. Food and Drug Administration (FDA) has agreed to review a request by Adamas Pharmaceuticals to approve ADS-5102 (amantadine…
Ana holds a PhD in immunology from the University of Lisbon and worked as a postdoctoral researcher at Instituto de Medicina Molecular (iMM) in Lisbon, Portugal. Ana was awarded two FCT fellowships and has won the Portuguese Immunology Society Best Paper and Best Poster award in 2009 and 2010, as well as the CESPU International Research Award in 2010. After leaving the lab to pursue a career in science communication, she served as the director of science communication at iMM Lisbon.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
The U.S. Food and Drug Administration (FDA) has agreed to review a request by Adamas Pharmaceuticals to approve ADS-5102 (amantadine…
Richard Myers, a Boston University School of Medicine (BUSM) professor of neurology, has just received a $100,000 grant from the Ellison Foundation to…
Researchers have discovered that welders develop symptoms of parkinsonism — a general term referring to disorders that cause movement problems…
President Obama recently signed into law the $6.3 billion 21st Century Cures Act, giving the U.S. Food and Drug…
Evotec and Celgene Corporation are collaborating on disease-modifying treatments for Parkinson’s, Alzheimer’s and other neurodegenerative diseases. The companies will use…
Sage Therapeutics has started a Phase 2 clinical trial of its drug candidate SAGE-217 in both mood and movement…
MeiraGTx will expand its neurodegenerative disease gene therapy pipeline to include Alzheimer’s disease (AD) and Parkinson’s disease (PD). Recent…
Voyager Therapeutics has reported positive interim six- and 12-month data from its ongoing Phase 1b clinical trial, showing that…
The National Institutes for Health (NIH) will grant Emory University more $1 million annually for the next five years to…
Researchers in Ireland are reporting that people with Parkinson’s disease (PD) are being admitted to hospitals at increasing rates…
Get regular updates to your inbox.